Francisca Iniesta-Martinez
Overview
Explore the profile of Francisca Iniesta-Martinez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
40
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Millan-Pascual J, Valero-Lopez G, Iniesta-Martinez F, Hellin-Gil M, Jimenez-Veiga J, Lopez-Tovar I, et al.
Neurol Ther
. 2023 Dec;
13(1):153-164.
PMID: 38097868
Introduction: The risk of SARS-CoV-2 infection or severe coronavirus disease 2019 (COVID-19) has been shown to increase in patients with multiple sclerosis (MS). Vaccination is recommended in this patient population,...
2.
Valero-Lopez G, Millan-Pascual J, Iniesta-Martinez F, Delgado-Marin J, Jimenez-Veiga J, Tejero-Martin A, et al.
Mult Scler Relat Disord
. 2022 Jul;
66:104038.
PMID: 35870370
Background: Pregnancy planning in women with highly active multiple sclerosis (HAMS) who need a high-efficacy disease-modifying therapy (heDMT) currently requires a careful risk-benefit evaluation. This includes minimizing fetal drug toxicity...
3.
Fuentes-Rumi L, Hernandez-Clares R, Carreon-Guarnizo E, Valero-Lopez G, Iniesta-Martinez F, Cabrera-Maqueda J, et al.
Mult Scler Relat Disord
. 2020 Jun;
44:102311.
PMID: 32593958
Background: Natalizumab (NTZ) is a disease-modifying treatment (DMT) in multiple sclerosis (MS) whose discontinuation can produce a "rebound effect", consisting of severe clinical deterioration and/or evidence of disease reactivation on...
4.
Odqvist L, Sanchez-Beato M, Montes-Moreno S, Martin-Sanchez E, Pajares R, Sanchez-Verde L, et al.
Clin Cancer Res
. 2013 Mar;
19(9):2319-30.
PMID: 23536439
Purpose: Peripheral T-cell lymphomas (PTCL) are a heterogeneous entity of neoplasms with poor prognosis, a lack of effective therapies, and a largely unknown molecular pathology. Deregulated NF-κB activity has been...